• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN LP LLC NORTH HAVEN SURGIPRO; MESH, SURGICAL, POLYMERIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN LP LLC NORTH HAVEN SURGIPRO; MESH, SURGICAL, POLYMERIC Back to Search Results
Model Number SPMM-46
Medical Device Problem Codes Migration or Expulsion of Device (1395); Mechanics Altered (2984); Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Abdominal Pain (1685); Adhesion(s) (1695); Diarrhea (1811); Emotional Changes (1831); Hemorrhage/Blood Loss/Bleeding (1888); Inflammation (1932); Nausea (1970); Pain (1994); Scar Tissue (2060); Seroma (2069); Hernia (2240); Discomfort (2330); Ascites (2596); Fluid Discharge (2686); Fibrosis (3167); Nodule (4551); Unspecified Tissue Injury (4559); Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available (4581)
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of a umbilical hernia.It was reported that after implant, the patient experienced adhesions, and an abdominal wall mass.Post-operative patient treatment included mesh removal surgery, abdominal wall mass excision, hernia repair with mesh, and revision surgery.
 
Additional Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of a umbilical hernia.It was reported that after implant, the patient experienced chronic pain, inflammation, mesh migration, mental pain, disability, impairment, loss of enjoyment of life, defective mesh, adhesions, and an abdominal wall mass.Post-operative patient treatment included mesh removal surgery, abdominal wall mass excision, hernia repair with mesh, and revision surgery.
 
Event or Problem Description
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of a umbilical hernia.It was reported that after implant, the patient experienced chronic pain, inflammation, mesh migration, mental pain, disability, impairment, loss of enjoyment of life, defective mesh, adhesions, abdominal wall mass, mesh wadded up, fibrotic tissue, fluid collection, seroma, hemorrhage, thick dense fibrotic wall, nausea, abdominal wall pain, scar tissue, tenderness, abdominal pain, recurrence, diarrhea, serous discharge.Post-operative patient treatment included mesh removal surgery, abdominal wall mass excision, hernia repair with mesh, revision surgery, ct scan, abdominal wall exploration, use of abdominal binder, use of blake drain.
 
Additional Manufacturer Narrative
Additional info: h6 (patient codes).Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Additional Manufacturer Narrative
Additional info: a4, b5, b7.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event or Problem Description
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of a umbilical hernia.It was reported that after implant, the patient experienced chronic pain, inflammation, mesh migration, mental pain, disability, impairment, loss of enjoyment of life, defective mesh, adhesions, abdominal wall mass, mesh wadded up, fibrotic tissue, fluid collection, seroma, hemorrhage, thick dense fibrotic wall, nausea, abdominal wall pain, scar tissue, tenderness, abdominal pain, recurrence, diarrhea, & serous discharge.Post-operative patient treatment included mesh removal surgery, abdominal wall mass excision, primary closure of hernia, hernia repair with mesh, revision surgery, ct scan, abdominal wall exploration, use of abdominal binder, & use of blake drain.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SURGIPRO
Common Device Name
MESH, SURGICAL, POLYMERIC
Manufacturer (Section D)
COVIDIEN LP LLC NORTH HAVEN
195 mcdermott rd
north haven CT 06473
Manufacturer (Section G)
COVIDIEN LP LLC NORTH HAVEN
195 mcdermott rd
north haven CT 06473
Manufacturer Contact
justin ellis
8200 coral sea st ne
mounds view,mn, CO 55112
7635265677
MDR Report Key11861117
Report Number1219930-2021-02009
Device Sequence Number19764258
Product Code FTL
UDI-Device Identifier10884521101432
UDI-Public10884521101432
Combination Product (Y/N)N
Initial Reporter StateMA
Initial Reporter CountryUS
PMA/510(K) Number
K915526
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2017
Device Explanted Year2019
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Consumer
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup,Followup,Followup
Report Date (Section B) 02/20/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date10/01/2019
Device Model NumberSPMM-46
Device Catalogue NumberSPMM-46
Device Lot NumberA4K0667X
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/05/2021
Supplement Date Received by Manufacturer01/26/2022
05/03/2023
02/19/2025
Initial Report FDA Received Date05/20/2021
Supplement Report FDA Received Date02/18/2022
05/15/2023
02/20/2025
Date Device Manufactured10/14/2014
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
SYM9 STEX RND 9CM X1 (LOT#PSK0123X).; SYM9 STEX RND 9CM X1 (LOT#PSK0123X)
Outcome Attributed to Adverse Event Required Intervention; Disability;
Patient SexMale
Patient Weight107 KG
Patient EthnicityHispanic
-
-